Difference between revisions of "User:Elizabethdavis"
(Created page with "thumb|Elizabeth Davis, MD Dr. Davis is an Assistant Professor of Medicine at Vanderbilt University Medical Center. She specializes in the treatmen...") |
m |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | [[File: | + | [[File:Elizabethdavis2.jpg|thumb|Elizabeth Davis, MD]] |
Dr. Davis is an Assistant Professor of Medicine at Vanderbilt University Medical Center. She specializes in the treatment of patients with bone and soft tissue sarcoma. Dr. Davis's primary research interests involve improving the medical management of sarcoma patients through the creation of novel treatment regimens and early phase clinical trials. She is interested in understanding drug resistance to current agents and exploring how the genetic differences in sarcoma subtypes can guide the development of targeted therapy. She serves as a clinical investigator on numerous clinical trials and is an active member of the American Society for Clinical Oncology, the Connective Tissue Oncology Society, and the Sarcoma Alliance for Research through Collaboration. | Dr. Davis is an Assistant Professor of Medicine at Vanderbilt University Medical Center. She specializes in the treatment of patients with bone and soft tissue sarcoma. Dr. Davis's primary research interests involve improving the medical management of sarcoma patients through the creation of novel treatment regimens and early phase clinical trials. She is interested in understanding drug resistance to current agents and exploring how the genetic differences in sarcoma subtypes can guide the development of targeted therapy. She serves as a clinical investigator on numerous clinical trials and is an active member of the American Society for Clinical Oncology, the Connective Tissue Oncology Society, and the Sarcoma Alliance for Research through Collaboration. | ||
| + | |||
| + | She is the HemOnc.org Section Editor of [[:Category:Sarcoma_regimens|Sarcoma]]. | ||
Latest revision as of 13:40, 3 October 2019
Dr. Davis is an Assistant Professor of Medicine at Vanderbilt University Medical Center. She specializes in the treatment of patients with bone and soft tissue sarcoma. Dr. Davis's primary research interests involve improving the medical management of sarcoma patients through the creation of novel treatment regimens and early phase clinical trials. She is interested in understanding drug resistance to current agents and exploring how the genetic differences in sarcoma subtypes can guide the development of targeted therapy. She serves as a clinical investigator on numerous clinical trials and is an active member of the American Society for Clinical Oncology, the Connective Tissue Oncology Society, and the Sarcoma Alliance for Research through Collaboration.
She is the HemOnc.org Section Editor of Sarcoma.